Telogen Effluvium Induced by COVID-19
June 2023
in “
Piel
”
Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Research cited in this study
27 / 27 resultsresearch Hair Loss and Telogen Effluvium Related to COVID-19: The Potential Implication of Adipose-Derived Mesenchymal Stem Cells and Platelet-Rich Plasma as Regenerative Strategies
This review discusses the increased incidence of hair loss and telogen effluvium among COVID-19 patients and evaluates existing evidence for regenerative treatments like PRP and HFSCs, finding limited published data.
research Characteristics of Hair Loss After COVID-19: A Systematic Scoping Review
This review identifies existing evidence on the connection between COVID-19 and hair loss, suggesting that hair loss associated with COVID-19 may primarily involve telogen effluvium and be reversible.
research Covid Induced Telogen Effluvium: An Insight
This review discusses post-COVID hair loss, attributing it to potential pathogenic factors like cytokines and viral effects, and suggests that full recovery without specific treatment is expected.
research Ultrastructural Evidence for Anagen Hair Follicle Infection with SARS-CoV-2 in Early-Onset COVID-19 Effluvium
This study describes the presence of SARS-CoV-2 in hair follicles from a patient with early-onset post-COVID hair loss, suggesting a potential direct impact of the virus on hair physiology.
research Management of Hair Loss After Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Insight Into the Pathophysiology With Implication for Better Management
This narrative review found that post-COVID-19 hair loss, particularly telogen effluvium, poses a significant mental and social burden, with minoxidil potentially aiding recovery, although more clinical research is needed to confirm its effectiveness.
research Alopecia in Patients with COVID-19: A Systematic Review and Meta-Analysis
This review analyzed data on alopecia types associated with COVID-19, suggesting androgenetic alopecia may be a risk factor for severe COVID-19, while telogen effluvium often follows infection and alopecia areata tends to relapse in those with preexisting disease.
research A Systematic Review of Acute Telogen Effluvium, a Harrowing Post-COVID-19 Manifestation
This systematic review reports that acute telogen effluvium may occur as a stress-induced hair loss following COVID-19 recovery, with most patients experiencing hair regrowth over time.
research COVID-19 Induced Telogen Effluvium
This study found that approximately one-quarter of post-COVID-19 patients experienced telogen effluvium, with a higher incidence among women, hospitalized patients, and those with hypertension or respiratory symptoms.
research More Than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis
In this study, researchers estimated that 80% of patients infected with SARS-CoV-2 experienced at least one long-term symptom, with fatigue being the most common.
research Trichodynia and Telogen Effluvium in COVID-19 Patients: Results of an International Expert Opinion Survey on Diagnosis and Management
This study found that telogen effluvium and trichodynia are common in patients after COVID-19, and their severity may be influenced by the severity of the COVID-19 infection.
research Time of Onset and Duration of Post-COVID-19 Acute Telogen Effluvium
This study found that acute telogen effluvium after COVID-19 typically began about 1.5 months post-infection and resolved sooner than typical cases, with most resolving in under two months.
research Telogen Effluvium in the New SARS-CoV-2 Era
COVID-19 and related stress may increase hair loss known as Telogen effluvium.
research Telogen Effluvium: A Review of the Science and Current Obstacles
This review describes the diagnosis and management challenges of telogen effluvium, a type of hair loss triggered by physiological stress, and summarizes current understanding of its mechanisms and treatments while recommending future research directions.
research Telogen Effluvium After SARS-CoV-2 Infection: A Series of Cases and Possible Pathogenetic Mechanisms
This study observed that telogen effluvium, or acute hair loss, often occurs 1 to 3 months after SARS-CoV-2 infection, earlier than classic telogen effluvium.
research SARS-CoV-2-Induced Telogen Effluvium: A Multicentric Study
This article discusses SARS-CoV-2-induced telogen effluvium in a multicentric study and reports no new clinical results.
research Acute Telogen Effluvium Associated with SARS-CoV-2 Infection
A woman's sudden hair loss was linked to her previous COVID-19 infection.
research Relative Changes in the Pattern of Diseases Presenting in Dermatology Outpatient Clinic in the Era of the COVID-19 Pandemic
This study observed a significant increase in certain dermatologic conditions a month and two months after the onset of the COVID-19 pandemic in Turkey, which may suggest a link with asymptomatic COVID-19 infection.
research Telogen Effluvium: A Review of the Literature
This review discusses the causes, diagnosis, and treatment of telogen effluvium and reports no new clinical findings; the authors underscore the importance of identifying and eliminating causative factors.
research Telogen Effluvium: A Comprehensive Review
This essay discusses telogen effluvium, the issues surrounding its diagnosis and differentiation from other forms of hair loss, and emphasizes the need for empathetic patient care; it reports no new clinical findings.
research Trichodynia: A Review of the Literature
This abstract reviews the symptom of trichodynia, a painful scalp sensation linked to hair loss, and highlights its potential connection to inflammation but reports no new research findings.
research Telogen Effluvium: A Review
This review discusses the various triggers and diagnostic challenges in determining the cause of telogen effluvium-related hair loss, without providing new clinical results.
research Telogen Effluvium: A Review of Acute and Chronic Forms
This review discusses telogen effluvium, a common type of hair loss, focusing on differentiation from other conditions and potential causes, but presents no new research findings.
research Dihydrotestosterone-Inducible IL-6 Inhibits Elongation of Human Hair Shafts by Suppressing Matrix Cell Proliferation and Promotes Regression of Hair Follicles in Mice
IL-6 contributes to hair loss by shortening the growth phase and causing hair follicles to regress.
research Enoxaparin-Induced Alopecia in Patients with Cerebral Venous Thrombosis
This study reported that enoxaparin may cause alopecia in patients treated for cerebral venous thrombosis, with hair growth resuming naturally after the treatment ended.
research Telogen Effluvium: Causes, Diagnosis, and Treatment
This article reviews the concept of telogen effluvium and emphasizes the importance of identifying triggers and using diagnostic investigations to determine the cause of hair loss, without reporting new results.
research Drug-Induced Hair Loss and Hair Growth
Some drugs can cause hair loss or increase hair growth, but these effects are usually reversible when the drug is stopped.
research Telogen Effluvium: A Comprehensive Review
This article proposes five different mechanisms for telogen effluvium, supported by clinical findings, based on changes in different phases of the hair cycle.
Similar Research
5 / 1000+ resultsresearch EFLÚVIO TELÓGENO E ALOPECIA AREATA ASSOCIADOS AO COVID-19
research Efluvio telógeno: uma sequela pos-COVID 19
This study's systematic review found that many individuals recovering from COVID-19 experience high rates of telogen effluvium, a common form of hair loss, highlighting limited epidemiological data and the need for further investigation into this condition post-COVID-19.
research Efluvio telógeno y Covid-19
This review discusses the potential relationship between Telogen effluvium and COVID-19 and reports no new clinical findings, highlighting the impact on patients' lives and the need for further investigation.
research Eflúvio Telógeno pós-COVID: uma revisão integrativa
This review reports that post-COVID telogen effluvium may be influenced by immune and psychological factors linked to COVID-19 infection, affecting hair loss.
research INFLUÊNCIA DO VÍRUS DA COVID-19 NO AUMENTO DO NÚMERO DE CASOS DE EFLÚVIO TELÓGENO
This study explored the potential link between an increase in telogen effluvium cases and COVID-19, suggesting that the infection's trigger factors may directly influence this hair loss condition, underscoring the need for effective treatment strategies.